©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Dec 15, 2014; 6(12): 438-440
Published online Dec 15, 2014. doi: 10.4251/wjgo.v6.i12.438
Published online Dec 15, 2014. doi: 10.4251/wjgo.v6.i12.438
Neoadjuvant chemoradiotherapy for locally advanced rectal cancer: The debate continues
Francesca De Felice, Daniela Musio, Vincenzo Tombolini, Department of Radiotherapy, Policlinico Umberto I “Sapienza” University of Rome, 00161 Rome, Italy
Luciano Izzo, Department of Surgery “Pietro Valdoni”, Policlinico Umberto I “Sapienza” University of Rome, 00161 Rome, Italy
Vincenzo Tombolini, Spencer-Lorillard Foundation, 00161 Rome, Italy
Author contributions: De Felice F wrote the editorial; De Felice F, Musio D, Izzo L and Tombolini V gave final approval.
Correspondence to: Francesca De Felice, MD, Department of Radiotherapy, Policlinico Umberto I “Sapienza” University of Rome, Viale Regina Elena 326, 00161 Rome, Italy. fradefelice@hotmail.it
Telephone: +39-06-49973411 Fax: +39-06-49973411
Received: September 17, 2014
Revised: November 3, 2014
Accepted: November 17, 2014
Published online: December 15, 2014
Processing time: 91 Days and 22.9 Hours
Revised: November 3, 2014
Accepted: November 17, 2014
Published online: December 15, 2014
Processing time: 91 Days and 22.9 Hours
Core Tip
Core tip: This editorial was planned to clarify the optimal treatment in patients with locally advanced rectal cancer, considering the results from CAO/ARO/AIO-04 trial.